ANDAORALCAPSULE
Lifecycle
Pre-Launch
Clinical Trials
20
Clinical Trials (5)
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Started Jan 2026
A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants
Started Jun 2025
The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib
Started Jun 2025
157 enrolled
Pulmonary Fibrosis
A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis
Started Jun 2025
2,000 enrolled
Interstitial Lung DiseasesSystemic Sclerosis Associated Interstitial Lung Disease
A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib
Started Oct 2024
50 enrolled
Idiopathic Pulmonary Fibrosis